Metolazone (Mylan Institutional Inc.)


Welcome to the PulseAid listing for the Metolazone drug offered from Mylan Institutional Inc.. This Increased Diuresis [PE],Thiazide-like Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional Inc.
NON-PROPRIETARY NAME: metolazone
SUBSTANCE NAME: METOLAZONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Thiazide-like Diuretic [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-04-15
END MARKETING DATE: 0000-00-00


Metolazone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMetolazone from Mylan Institutional Inc.
LABELER NAME: Mylan Institutional Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2005-04-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51079-023_c42a0e21-15b8-4cbe-8625-6a8f5fd0c226
PRODUCT NDC: 51079-023
APPLICATION NUMBER: ANDA076698

Other METOLAZONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aphena Pharma Solutions – Tennessee, LLCMetolazone
Avera McKennan Hospitalmetolazone
Cardinal HealthMetolazone
Carilion Materials ManagementMetolazone
Eon Labs, Inc.Metolazone
McKesson Packaging Services a business unit of McKesson CorporationMetolazone
Mylan Institutional Inc.Metolazone
Mylan Pharmaceuticals Inc.Metolazone
NCS HealthCare of KY, Inc dba Vangard LabsMetolazone
Physicians Total Care, Inc.Metolazone
Upstate Pharma, LLCmetolazone